Table 1 Demographic and clinical characteristics of the patients included in the study
Interval cholecystectomy (n = 138) | Non-interval cholecystectomy (n = 67) | P-value | |
|---|---|---|---|
Age (years) | 64.33 ± 14.61 | 73.40 ± 12.97 | < 0.001 |
Sex | 0.754 | ||
Female | 65 (47.10%) | 30 (44.78%) | |
Male | 73 (52.90%) | 37 (55.22%) | |
TG18 grade | < 0.001 | ||
Grade I | 95 (68.84%) | 38 (56.72%) | |
Grade II | 32 (23.19%) | 10 (14.93%) | |
Grade III | 11 (7.97%) | 19 (28.36%) | |
Laboratory test | |||
White blood cell (× 109/L) | 12.20 (8.12–15.68) | 10.16 (7.32–14.90) | 0.956 |
Direct bilirubin (μmol/L) | 11.60 (6.10–19.50) | 10.00 (5.47–46.92) | 0.099 |
Total bilirubin (μmol/L) | 22.40 (13.60–37.90) | 21.80 (11.50–61.70) | 0.238 |
Aspartate aminotransferase (U/L) | 26.00 (18.00–53.00) | 25.00 (17.00–53.00) | 0.566 |
Alanine aminotransferase (U/L) | 26.00 (16.00–60.00) | 23.00 (15.00–61.00) | 0.164 |
Serum creatinine (μmol/L) | 69.20 (55.70–87.25) | 69.30 (51.80–106.90) | 0.494 |
INR | 1.22 ± 0.13 | 1.35 ± 0.80 | 0.096 |
Platelet (× 109/L) | 189.37 ± 68.98 | 183.49 ± 76.10 | 0.587 |
Albumin stratification (g/L) | 0.004 | ||
> 35 | 42 (41.58%) | 11 (24.44%) | |
28–35 | 50 (49.50%) | 21 (46.67%) | |
< 28 | 9 (8.91%) | 13 (28.89%) | |
Image performance | |||
Gallbladder distention (> 4 cm) | 129 (93.48%) | 65 (97.01%) | 0.292 |
Thickened gallbladder wall (> 3 mm) | 135 (97.83%) | 64 (95.52%) | 0.359 |
Gallstones | 118 (85.51%) | 41 (63.08%) | < 0.001 |
Common bile duct stones | 27 (19.57%) | 14 (21.54%) | 0.744 |
Common bile duct dilatation (> 6 mm) | 34 (24.64%) | 17 (25.37%) | 0.909 |
Pericholecystic effusion | 70 (50.72%) | 33 (49.25%) | 0.843 |
Comorbidity | |||
Hypertension | 48 (34.78%) | 30 (44.78%) | 0.167 |
Diabetes | 23 (16.67%) | 14 (20.90%) | 0.460 |
Cardiovascular and cerebrovascular diseases | 40 (28.99%) | 34 (50.75%) | 0.002 |
History of malignancy | 11 (7.97%) | 18 (26.87%) | < 0.001 |
Liver cirrhosis | 2 (1.45%) | 0 (0.00%) | 0.322 |
Kidney disease | 4 (2.90%) | 4 (5.97%) | 0.287 |
Postoperative | |||
Septic shock | 4 (2.90%) | 4 (5.97%) | 0.287 |
Transfer to ICU | 4 (2.90%) | 2 (2.99%) | 0.972 |
Hospitalization days | 7 (5–11) | 6 (4–10) | 0.713 |
PC-related complications | 4 (2.90%) | 5 (7.46%) | 0.353 |
Clogged tube | 2 (1.45%) | 1 (1.49%) | 0.981 |
Dislodged tube | 2 (1.45%) | 4 (5.97%) | 0.072 |
Recurrence after PC | 19 (13.77%) | 15 (22.39%) | 0.120 |
All-cause deaths during follow-up | 1 (0.72%) | 19 (28.36%) | < 0.001 |